Latest Features

Type 2 Diabetes Hepatitis C Virus: An Increased Risk For Type 2 Diabetes

Hepatitis C Virus: An Increased Risk For Type 2 Diabetes

Type 2 diabetes risk appears to be increased in patients with hepatitis C virus and related disorders.

Type 1 Diabetes Case Study: Diabetic Ketoacidosis Concerns in Type 1 Diabetes

Case Study: Diabetic Ketoacidosis Concerns in Type 1 Diabetes

After 3 days without taking insulin, a patient presents to the emergency room with hyperglycemia and concerns of diabetic ketoacidosis.

Bone Metabolism Osteoporosis Treatment Approaches in Women vs Men

Osteoporosis Treatment Approaches in Women vs Men

A review of osteoporosis diagnosis, treatment, and management in both men and women.

Practice Management The Ugly Truth: Persistent Sexism in Medicine

The Ugly Truth: Persistent Sexism in Medicine

Elise Barney, DO, discusses the subtleties of modern sexism in medicine in a candid interview.

Practice Management The Current State of Medical Liability Reform

The Current State of Medical Liability Reform

Current overall costs for medical liability in the United States range from $55.6 to $200 billion annually, which accounts for 2.4% to 10% of all healthcare spending.

Type 1 Diabetes Diabulimia: Comorbid Type 1 Diabetes and Eating Disorders

Diabulimia: Comorbid Type 1 Diabetes and Eating Disorders

Dual diagnosis of an eating disorder with type 1 diabetes -- known as diabulimia -- is a newly-recognized psychiatric illness in this patient population.

Type 2 Diabetes Type 2 Diabetes Therapy Intensification: Part II: GLP-1 Agonist Adverse Effects and Fixed-Ratio Combinations

Type 2 Diabetes Therapy Intensification: Part II: GLP-1 Agonist Adverse Effects and Fixed-Ratio Combinations

When basal insulin no longer provides adequate glucose control in type 2 diabetes, a rapid-acting insulin or a glucagon-like peptide-1 receptor agonist may be used to intensify therapy.

AACE_2017 American Association of Clinical Endocrinologists 2017 Meeting Preview

American Association of Clinical Endocrinologists 2017 Meeting Preview

First look at research being presented at AACE 2017.

Type 2 Diabetes Type 2 Diabetes Therapy Intensification: Part I: Insulin vs GLP-1 Agonists

Type 2 Diabetes Therapy Intensification: Part I: Insulin vs GLP-1 Agonists

When basal insulin no longer provides adequate glucose control in type 2 diabetes, a rapid-acting insulin or a glucagon-like peptide-1 receptor agonist may be used to intensify therapy.

Androgen and Reproductive Disorders Migraine Management in Female Reproduction

Migraine Management in Female Reproduction

The relationship between hormones and migraine is most frequently pronounced during the female reproductive years.

Practice Management Q&A: Health Law Expert on the Current State of Medical Malpractice

Q&A: Health Law Expert on the Current State of Medical Malpractice

An interview with medical malpractice expert, Michelle Mello, JD, PhD.

Practice Management ACA: Improving Health Care for Medicaid Beneficiaries

ACA: Improving Health Care for Medicaid Beneficiaries

Despite improved coverage, many Medicaid beneficiaries experienced increased wait times.

Home Analyzing Trends and Recent Controversies in Cardiovascular Nutrition

Analyzing Trends and Recent Controversies in Cardiovascular Nutrition

Recent evidence clearly indicates that patients should be eating whole foods rather than attempting to get vitamins and antioxidants from dietary supplements.

ENDO 2017 ENDO 2017: What To Watch For

ENDO 2017: What To Watch For

First look at research being presented at ENDO 2017.

Practice Management Best Practices for Transitioning Patients from Pediatric to Adult Care

Best Practices for Transitioning Patients from Pediatric to Adult Care

The transition process should adequately prepare both the child and their family to move in to the world of adult care.

Practice Management Q&A: Obtaining Informed Consent in Clinical Research

Q&A: Obtaining Informed Consent in Clinical Research

Obtaining informed consent is crucial in medical research, and new methods of obtaining consent are aiming to make study information more readily accessible.

Home Underreporting Negative Clinical Trial Data Raises Ethical Concerns With WHO, FDA, NIH

Underreporting Negative Clinical Trial Data Raises Ethical Concerns With WHO, FDA, NIH

A number of organizations recently raised ethical concerns linked to researchers not reporting negative results of clinical trials.

Practice Management Medical Device Safety: A Call For Improvement

Medical Device Safety: A Call For Improvement

A large number of product recalls for various medical devices indicates the need for more regulation prior to approval, and more active monitoring after devices hit the market.

Type 2 Diabetes Preoperative Glargine Dosing May Affect Perioperative Glycemic Control

Preoperative Glargine Dosing May Affect Perioperative Glycemic Control

Patients who received 60% to 87% of the normal evening glargine dose had the highest likelihood of achieving glycemic control.

Diabetes Rising Insulin Prices: ADA & Endocrine Society Call for Action

Rising Insulin Prices: ADA & Endocrine Society Call for Action

The American Diabetes Association and the Endocrine Society have issued statements with the intent of improving insulin access and affordability.

Sign Up for Free e-Newsletters